# Implementation Status

## Current phase

Phase 2 — CTD Authoring Foundation, first vertical slice.

## Completed

- Canonical document review and historical-delta review
- Empty-repository discovery
- Stack, architecture, content-governance, and validation decisions
- Local Git repository and `codex/ctd-authoring-foundation` branch
- CTD Builder, Module 3, Drug Product index, `3.2.P.5`, Source-to-CTD Matrix, and methodology routes
- Typed Zod schemas, structured safe sample data, and a pure deterministic readiness evaluator
- Source/readiness status filters, progressive disclosure, text/CSV export, and print layout
- Reusable citation, status, trust, readiness, navigation, and matrix components
- Unit, component, route, keyboard, axe, console, responsive, print, and production-build validation

## Decisions and assumptions

- This is a new repository because the selected directory contained no prior application.
- Current content follows M4Q(R1); M4Q(R2) is draft and is not used as current mandatory content.
- Official source metadata and links can be verified independently from editorial synthesis.
- No content is labeled human-reviewed without a recorded qualified review.
- Demonstration records contain no proprietary technical values.

## Regulatory verification status

- Official ICH/FDA/EMA source URLs and current/draft status: source-checked on 2026-07-13.
- Section summaries, authoring prompts, reviewer lens, consistency checks, and deficiency signals: editorial draft; qualified regulatory review required.

## Known limitations

- Only Module 3 `3.2.P.5` is fully implemented.
- No application-specific intake, confidential workspace, persistence, authentication, or GxP controls.
- Readiness is a demonstration authoring workflow state, not an agency completeness determination.
- No GitHub remote is connected yet.

## Validation result

- Formatting check: pass
- ESLint with zero warnings: pass
- Strict TypeScript check: pass
- Vitest: 5 files, 12 tests passed
- Next.js production build: pass; all application routes statically rendered
- Playwright production-server review: 24 tests passed across desktop Edge and mobile emulation
- axe WCAG A/AA scan: no detected violations on the `3.2.P.5` reference page
- Keyboard controls, print media, source filters, console errors, and desktop/mobile screenshots: pass
- npm audit: 0 known vulnerabilities after the lock-file override for patched PostCSS

## Exact validation commands

```bash
npm run format:check
npm run lint
npm run typecheck
npm run test
npm run build
npm run test:e2e
```

## Remaining tasks in dependency order

1. Complete qualified regulatory review and attach a real review record for `3.2.P.5` editorial synthesis.
2. Add `3.2.P.1`, `3.2.P.2`, `3.2.P.3`, `3.2.P.7`, and `3.2.P.8` through the validated section model.
3. Add linked `2.3` Quality Overall Summary traceability.
4. Expand cross-module consistency rules and reviewer-readiness fixtures.
5. Connect Module 3 records to Change Impact Navigator and inspection-evidence traceability.
